British American Tobacco Ends Contract With Tech Firm Producing 'Low-Nicotine' Cigarettes
British American Tobacco has ended a contract with a biotechnology firm doing nicotine science with ties to the Piedmont.
British American Tobacco has ended a contract with a biotechnology firm doing nicotine science with ties to the Piedmont.
The innovative drug Ocrevus looks as if it could be a game-changer for people with MS. But it's very, very expensive. And as with any new medication, the long-term safety risks are unknown.